Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients.
Atreya CE, Collisson EA, Park M, Grenert JP, Behr SC, Gonzalez A, Chou J, Maisel S, Friedlander TW, Freise CE, Shoji J, Semrad TJ, Van Ziffle J, Chin-Hong P. Atreya CE, et al. Among authors: semrad tj. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1446-1452. doi: 10.6004/jnccn.2020.7622. Print 2020 Nov. J Natl Compr Canc Netw. 2020. PMID: 33152701
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
Chen JA, Huynh JC, Wu CY, Yu AM, Matsukuma K, Semrad TJ, Gandara DR, Li T, Riess JW, Tam K, Mack PC, Martinez A, Mahaffey N, Kelly KL, Kim EJ. Chen JA, et al. Among authors: semrad tj. Cancer Chemother Pharmacol. 2022 Sep;90(3):217-228. doi: 10.1007/s00280-022-04457-9. Epub 2022 Jul 30. Cancer Chemother Pharmacol. 2022. PMID: 35907014 Free PMC article. Clinical Trial.
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors.
Liu SV, Groshen SG, Kelly K, Reckamp KL, Belani C, Synold TW, Goldkorn A, Gitlitz BJ, Cristea MC, Gong IY, Semrad TJ, Xu Y, Xu T, Koczywas M, Gandara DR, Newman EM. Liu SV, et al. Among authors: semrad tj. Cancer Chemother Pharmacol. 2018 Oct;82(4):723-732. doi: 10.1007/s00280-018-3672-y. Epub 2018 Aug 20. Cancer Chemother Pharmacol. 2018. PMID: 30128950 Free PMC article. Clinical Trial.
Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy.
Zimmermann M, Li T, Semrad TJ, Wu CY, Yu A, Cimino G, Malfatti M, Haack K, Turteltaub KW, Pan CX, Cho M, Kim EJ, Henderson PT. Zimmermann M, et al. Among authors: semrad tj. Mol Cancer Ther. 2020 Apr;19(4):1070-1079. doi: 10.1158/1535-7163.MCT-19-0133. Epub 2020 Feb 6. Mol Cancer Ther. 2020. PMID: 32029633 Free PMC article.
39 results